Kristie Blum

Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 21

  1. 1
  2. 2
  3. 3

Article

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

by Narendranath Epperla; Jeffrey Switchenko; Veronika Bachanova; James N Gerson; Stefan K Barta; Max J Gordon; Alexey V Danilov; Natalie S Grover; Stephanie Mathews; Madelyn Burkart; Reem Karmali; Yazeed Sawalha; Brian T Hill; Nilamjan Ghosh; Steven I Park; David A Bond; Mehdi Hamadani; Timothy S Fenske; Peter Martin; Mary-Kate Malecek; Brad S Kahl; Christopher Flowers; Brian K Link; Lawrence D Kaplan; David J Inwards; Andrew L Feldman; Eric D Hsi; Kami Maddocks; Kristie Blum; Nancy L Bartlett; James R Cerhan; John P Leonard; Thomas M Habermann; Matthew J Maurer; Jonathon Cohen

2023

Article

Complete Response to Induction Therapy in Patients With Myc-Positive and Double-Hit Non-Hodgkin Lymphoma Is Associated With Prolonged Progression-Free Survival

by Jonathon B Cohen; Susan M. Geyer; Gerard Lozanski; Weiqiang Zhao; Nyla A. Heerema; Nathan C. Hall; Veena A. Nagar; Jessica A. Hemminger; Jeffrey A. Jones; Pierluigi Porcu; Beth A. Christian; Robert A. Baiocchi; Kami J. Maddocks; Joseph M. Flynn; Steven M. Devine; Kristie Blum

2014

Article

A phase 2 trial of alisertib in patients with relapsed or refractory B-cellnon-Hodgkin lymphoma

by Jonathon Cohen; Kami J. Maddocks; Ying Huang; Beth A. Christian; Samantha M. Jaglowski; Christopher Flowers; Kristie Blum

2017

Article

A Phase I Study of Pelabresib (CPI-0610), a Small-Molecule Inhibitor of BET Proteins, in Patients with Relapsed or Refractory Lymphoma.

by Kristie Blum; Jeffrey G Supko; Michael B Maris; Ian W Flinn; Andre Goy; Anas Younes; Suresh Bobba; Adrian M Senderowicz; Sergey Efuni; Ronda Rippley; Gozde Colak; Patrick Trojer; Jeremy S Abramson

2022

Article

A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma

by Walter Hanel; Polina Shindiapina; David A Bond; Yazeed Sawalha; Narendranath Epperla; Timothy Voorhees; Rina L Welkie; Ying Huang; Gregory K Behbehani; Xiaoli Zhang; Eric McLaughlin; Wing K Chan; Jonathan E Brammer; Samantha Jaglowski; John C Reneau; Beth A Christian; Basem M William; Jonathon Cohen; Robert A Baiocchi; Kami Maddocks; Kristie Blum; Lapo Alinari

2023

Article

Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era

by Reem Karmali; Jeffrey Switchenko; Subir Goyal; Krithika Shanmugasundaram; Michael C Churnetski; Bhaskar Kolla; Veronika Bachanova; James N Gerson; Stefan K Barta; Max J Gordon; Alexey Danilov; Natalie S Grover; Narendranath Epperla; Stephanie Mathews; Madelyn Burkart; Yazeed Sawalha; Brian T Hill; Nilanjan Ghosh; Steven Park; David A Bond; Kami J Maddocks; Talha Badar; Timothy S Fenske; Mehdi Hamadani; Jin Guo; Mary Malecek; Brad S Kahl; Peter Martin; Kristie Blum; Christopher Flowers; Jonathon Cohen

2021

Article

Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival

by Krithika Shanmugasundaram; Subir Goyal; Jeffrey Switchenko; Oscar Calzada; Michael C Churnetski; Bhaskar Kolla; Veronika Bachanova; James N Gerson; Stefan K Barta; Max J Gordon; Alexey V Danilov; Natalie S Grover; Stephanie Mathews; Madelyn Burkart; Reem Karmali; Yazeed Sawalha; Brian T Hill; Nilanjan Ghosh; Steven I Park; Narendranath Epperla; David A Bond; Talha Badar; Kristie Blum; Mehdi Hamadani; Timothy S Fenske; Mary Malecek; Brad S Kahl; Peter Martin; Jin Guo; Christopher Flowers; Jonathon Cohen

2021

Article

HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis

by Juan Pablo Alderuccio; Adam J Olszewski; Andrew M Evens; Graham P Collins; Alexey Danilov; Mark Bower; Deepa Jagadeesh; Catherine Zhu; Amy Sperling; Seo-Hyun Kim; Ryan Vaca; Catherine Wei; Suchitra Sundaram; Nishitha Reddy; Alessia Dalla Pria; Christopher D'Angelo; Umar Farooq; David A Bond; Stephanie Berg; Micheal C Churnetski; Amandeep Godara; Nadia Khan; Yun Kyong Choi; Shireen Kassam; Maryam Yazdy; Emma Rabinovich; Frank A Post; Gaurav Varma; Reem Karmali; Madelyn Burkart; Peter Martin; Albert Ren; Ayushu Chauhan; Catherine Diefenbach; Allandria Straker-Edwards; Andreas Klein; Kristie Blum; Kirsten Marie Boughan; Agrima Mian; Bradley M Haverkos; Victor Orellana-Noia; Vaishalee P Kenkre; Adam Zayac; Seth M Maliske; Narendranath Epperla; Paolo Caimi; Scott E Smith; Manali Kamdar; Parameswaran Venugopal; Tatyana A Feldman; Daniel Rector; Stephen D Smith; Andrzej Stadnik; Craig A Portell; Yong Lin; Seema Naik; Silvia Montoto; Izidore S Lossos; Kate Cwynarski

2021

Article

Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study

by Adam S Zayac; Andrew M Evens; Alexey Danilov; Stephen D Smith; Deepa Jagadeesh; Lori A Leslie; Catherine Wei; Seo-Hyun Kim; Seema Naik; Suchitra Sundaram; Nishitha Reddy; Umar Farooq; Vaishalee P Kenkre; Narendranath Epperla; Kristie Blum; Nadia Khan; Daulath Singh; Juan P Alderuccio; Amandeep Godara; Maryam Sarraf Yazdy; Catherine Diefenbach; Emma Rabinovich; Gaurav Varma; Reem Karmali; Yusra Shao; Asaad Trabolsi; Madelyn Burkart; Peter Martin; Sarah Stettner; Ayushi Chauhan; Yun Kyonh Choi; Allandria Straker-Edwards; Andreas Klein; Michael C Churnetski; Kirsten M Boughan; Stephanie Berg; Bradley M Haverkos; Victor Orellana-Noia; Christopher D'Angelo; David A Bond; Seth M Maliske; Ryan Vaca; Gabriella Magarelli; Amy Sperling; Max J Gordon; Kevin A David; Malvi Savani; Paolo Caimi; Manali Kamdar; Matthew A Lunning; Neil Palmisiano; Parameswaran Venugopal; Craig A Portell; Veronika Bachanova; Tycel Phillips; Izidore S Lossos; Adam J Olszewski

2021

Article

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy

by David A. Bond; Jeffrey Switchenko; Diego Villa; Kami Maddocks; Michael Churnetski; Alina S. Gerrie; Subir Goyal; Oscar Calzada; Bhaskar Kolla; Veronika Bachanova; James N. Gerson; Stefan K. Barta; Brian T. Hill; Yazeed Sawalha; Peter Martin; Edward Maldonado; Max Gordon; Alexey Danilov; Natalie S. Grover; Stephanie Mathews; Madelyn Burkart; Reem Karmali; Nilanjan Ghosh; Steven Park; Narendranath Epperla; Talha Badar; Jin Guo; Mehdi Hamadani; Timothy S. Fenske; Mary-Kate Malecek; Christopher Flowers; Brad S. Kahl; Kristie Blum; Jonathon Cohen

2021